Literature DB >> 7921622

Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats.

M Kähönen1, H Mäkynen, P Arvola, I Pörsti.   

Abstract

1. The effects of long-term atenolol (25 mg kg-1 day-1) therapy on arterial function were studied in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. The 14-week treatment attenuated the increase in blood pressure by approximately 30 mmHg in SHR, but did not affect blood pressure in WKY rats. 2. Responses of mesenteric arterial rings in vitro were examined at the end of the study. The relaxation to acetylcholine was similar in WKY rats and atenolol-treated SHR and more pronounced than in untreated SHR, whereas the relaxation to the nitric oxide donor 3-morpholinosydnonimine (SIN-1) was comparable in all study groups. Moreover, after maximal relaxations to acetylcholine, marked recontractions developed in untreated SHR but not in the other groups. Vasorelaxation to isoprenaline was also attenuated in SHR and was moderately improved by the atenolol therapy. 3. Arterial relaxation induced by return of potassium to the organ bath upon precontractions elicited by potassium-free solution were used to evaluate vascular smooth muscle Na+, K+-ATPase. The rate of potassium relaxation was fastest in WKY rats and was also faster in atenolol-treated than in untreated SHR. 4. The ability of vascular smooth muscle to sequester calcium was evaluated by eliciting responses to caffeine or noradrenaline after loading periods in different organ bath calcium concentrations. The subsequent contractions were lower in untreated SHR than in WKY rats, and augmented in SHR by the atenolol treatment. 5. Smooth muscle contractions to noradrenaline were comparable in SHR and WKY rats, while atenolol treatment slightly increased the maximal response to this agonist in SHR. Responses to potassium chloride were not affected by atenolol and contractions following cumulative re-addition of calcium to the organ bath after precontraction with potassium chloride and noradrenaline in calcium free solution were comparable in all study groups.6. In conclusion, the moderate antihypertensive effect of atenolol in SHR was accompanied by enhancement of beta-adrenoceptor-mediated and normalization of endothelium-dependent arterial relaxation.Furthermore, ability to sequester calcium into cellular stores, and function of Na+,K+-ATPase were augmented in vascular smooth muscle. Therefore, the present results suggest that the long-term blood pressure-lowering action of atenolol in this type of genetic hypertension is accompanied by improved arterial relaxation and normalization of endothelial function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921622      PMCID: PMC1910195          DOI: 10.1111/j.1476-5381.1994.tb13169.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

Review 1.  Changes in sodium pump activity and vascular contraction.

Authors:  M J Mulvany
Journal:  J Hypertens       Date:  1985-10       Impact factor: 4.844

2.  Mechanism of potassium relaxation of arterial muscle.

Authors:  A Bonaccorsi; K Hermsmeyer; O Aprigliano; C B Smith; D F Bohr
Journal:  Blood Vessels       Date:  1977

3.  Endothelial cells contain beta adrenoceptors.

Authors:  S F Steinberg; E A Jaffe; J P Bilezikian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

Review 4.  Na+,K+-ATPase inhibitors and the adrenergic neuroeffector interaction in the blood vessel wall.

Authors:  P M Vanhoutte; R R Lorenz
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

5.  Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol.

Authors:  P Lund-Johansen
Journal:  J Cardiovasc Pharmacol       Date:  1979 Sep-Oct       Impact factor: 3.105

6.  Left ventricular performance in spontaneously hypertensive rats after chronic beta 1-adrenoceptor blockade with atenolol.

Authors:  I K Lauva; R J Tomanek
Journal:  J Cardiovasc Pharmacol       Date:  1985 Mar-Apr       Impact factor: 3.105

7.  A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA/saline hypertensive and renal hypertensive rats.

Authors:  K Takeda; Y Nakagawa; W P Chin; S Imai
Journal:  Jpn J Pharmacol       Date:  1982-04

8.  Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.

Authors:  D L Luo; M Nakazawa; T Ishibashi; K Kato; S Imai
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

9.  Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats.

Authors:  P Chatelain; M Waelbroeck; J C Camus; P De Neef; P Robberecht; J Roba; J Christophe
Journal:  Eur J Pharmacol       Date:  1981-06-10       Impact factor: 4.432

10.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  T F Lüscher; P M Vanhoutte
Journal:  Hypertension       Date:  1986-04       Impact factor: 10.190

View more
  1 in total

1.  Effect of celiprolol therapy on arterial dilatation in experimental hypertension.

Authors:  J P Tolvanen; X Wu; M Kähönen; K Sallinen; H Mäkynen; A Pekki; I Pörsti
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.